Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ImmunoGen options antibody from Duke and Johns Hopkins

Nov. 18, 1999

RPR/INGN-201 + radiotherapy provides supraadditive effects in prostate cancer xenograft models

Nov. 17, 1999

Lorus files IND seeking clearance for phase I/II clinical trials of GTI-2040

Nov. 17, 1999

Foscan receives orphan drug designation in U.S.; MAA accepted in E.U.

Nov. 17, 1999

Pharmaceutical agents useful as vitronectin antagonists and methods of use

Nov. 17, 1999

Kinase inhibitors developed at Boehringer Ingelheim as potential anticancer agents

Nov. 17, 1999

Ontogen completes phase I multidose oral study of MDR compound

Nov. 17, 1999

Preclinical data highlight Xcytrin's anticancer activity and novel mechanism of action

Nov. 17, 1999

New data reported on thalidomide for several cancer indications

Nov. 17, 1999

OHSU study will evaluate vitamin D in patients with recurring prostate cancer

Nov. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...